Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity by Gökhan Güner, Marlene Aßfalg, Kai Zhao, Tobias Dreyer, Shibojyoti Lahiri, Yun Lo, Bianca Ionela Slivinschi, Axel Imhof, Georg Jocher, Laura Strohm, Christian Behrends, Dieter Langosch, Holger Bronger, Christopher Nimsky, Jörg W Bartsch, Stanley R Riddell, Harald Steiner, Stefan F Lichtenthaler

Get full text

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy by Paul Nghiem, Martin Cheever, Stanley R Riddell, Steven P Fling, Nirasha Ramchurren, Nathalie Labarrière, Sylvain Simon, Virginie Vignard, Tiffany Beauvais, Brigitte Dreno, Valentin Voillet, Zhong Wu, Camille Dabrowski, Nicolas Jouand, Amir Khammari, Cécile Braudeau, Régis Josien, Olivier Adotevi, Caroline Laheurte, François Aubin, Charles Nardin, Samuel Rulli, Raphael Gottardo, Candice D Church

Get full text

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL by Jordan Gauthier, Emily C. Liang, Jennifer J. Huang, Erik L. Kimble, Alexandre V. Hirayama, Salvatore Fiorenza, Jenna M. Voutsinas, Qian (Vicky) Wu, Carla A. Jaeger-Ruckstuhl, Barbara S. Pender, Delaney R. Kirchmeier, Aiko Torkelson, Kristina Braathen, Ryan Basom, Mazyar Shadman, Noam E. Kopmar, Ryan D. Cassaday, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle

Get full text